...
首页> 外文期刊>Abdominal imaging. >Acute symptomatic mesenteric venous thrombosis: treatment by catheter-directed thrombolysis with transjugular intrahepatic route.
【24h】

Acute symptomatic mesenteric venous thrombosis: treatment by catheter-directed thrombolysis with transjugular intrahepatic route.

机译:急性症状性肠系膜静脉血栓形成:采用经导管的肝内途径经导管定向溶栓治疗。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To assess the feasibility and effectiveness of transjugular intrahepatic route aspiration thrombectomy and catheter-directed thrombolytic therapy in patients with acute superior mesenteric venous thrombosis. MATERIALS AND METHODS: During a period of 8 years, 12 patients with acute thrombosis of the superior mesenteric vein (SMV) were treated by transjugular intrahepatic approach. The mean age was 41.2 years. After access to the portal system via the transjugular approach, the pigtail catheter fragmentation of the thrombus, local urokinase injection, and manual aspiration thrombectomy were used for treatment of the SMV thrombosis initially, followed by continuous thrombolytic therapy via an indwelling infusion catheter in the SMV, which was performed for 2 to 6 days (4.2 +/- 1.8 days). The adequacy of anticoagulation was performed during treatment, throughout hospitalization, and after discharge. RESULTS: Technical success was achieved in all 12 patients. Substantial clinical improvement was seen in these patients after the procedure. Minor complications at the jugular puncture site were observed in 4 patients, but the thrombolytic therapy was not interrupted. Contrast-enhanced computed tomography (CT) scan before discharge demonstrated nearly complete disappearance of SMV thrombosis in all patients. The 12 patients were discharged 5-10 days (7.6 +/- 2.0) after admission. Mean duration of follow-up after hospital discharge was 37.7 months, and no recurrent episodes of SMV thrombosis developed during that time period. CONCLUSION: Catheter-directed thrombus aspiration, mechanical fragmentation, and local thrombolytic infusion via the transjugular intrahepatic route is a safe and effective therapy for the management of patients with acute symptomatic SMV thrombosis.
机译:目的:探讨经颈静脉肝内途径穿刺血栓切除术和导管定向溶栓治疗在急性肠系膜上静脉血栓形成中的可行性和有效性。材料与方法:在8年的时间里,采用经颈静脉肝内入路治疗12例急性肠系膜上静脉血栓形成(SMV)患者。平均年龄为41.2岁。通过经颈静脉入路进入门静脉系统后,首先将猪尾巴的血栓导管碎片,局部尿激酶注射和手动抽吸血栓切除术用于治疗SMV血栓形成,然后通过SMV中的留置输液导管进行连续溶栓治疗,执行2到6天(4.2 +/- 1.8天)。在治疗过程中,整个住院期间以及出院后均进行足够的抗凝治疗。结果:全部12例患者均取得技术成功。这些患者在手术后看到了明显的临床改善。在4例患者中观察到了颈静脉穿刺部位的轻微并发症,但是溶栓治疗并未中断。出院前的对比增强计算机断层扫描(CT)扫描显示所有患者中SMV血栓形成几乎完全消失。该12例患者入院后5-10天(7.6 +/- 2.0)出院。出院后的平均随访时间为37.7个月,在此期间没有复发性SMV血栓形成。结论:经颈静脉肝内途径进行导管定向的血栓抽吸,机械破碎和局部溶栓治疗是治疗急性症状性SMV血栓形成的安全有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号